Skip to main content

Table 1 Demographic data and clinical characteristics

From: Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failure

Parameter

HC

(n = 30)

HEV-AVH

(n = 30)

HEV-ALF

(n = 17)

HEV-ACLF

(n = 36)

Age (yr)

41.34 ± 7.55

44.43 ± 4.38

46.43 ± 8.34

48.88 ± 10.67

Gender(M/F)

23/7

23/7

13/4

27/9

PTA (%)

83.54 ± 15.77

77.23 ± 16.87

42.33 ± 13.22

38.02 ± 14.34

FIB (g/L)

2.28 ± 0.67

2.13 ± 0.95

1.56 ± 0.54

1.43 ± 0.56

INR

1.31 ± 0.29

1.35 ± 0.34

2.01 ± 0.34

2.17 ± 0.45

WBC(1 × 109/L)

5.43 ± 1.24

5.21 ± 1.34

15.34 ± 6.67

16.28 ± 8.54

PLT (1 × 109/L)

223.47 ± 34.34

187.04 ± 56.21

123.65 ± 23.45

112.77 ± 62.43

ALT (U/L)

25.23 ± 12.34

25.45 ± 11.32

376.56 ± 399.23

389.52 ± 413.93

GLU (mM)

4.49 ± 0.65

4.65 ± 0.89

5.54 ± 2.23

5.74 ± 3.36

TBIL (μM)

14.33 ± 3.75

17.88 ± 7.98

296.66 ± 154.23

323.61 ± 134.52

CHOL (mM)

4.01 ± 0.39

3.25 ± 0.78

2.65 ± 18.56

2.54 ± 0.81

CREA (μM)

46.66 ± 11.54

55.61 ± 12.01

59.34 ± 15.76

63.54 ± 20.75

MELD

  

24.99 ± 4.23

25.15 ± 4.67

  1. ALT, alanine aminotransferase; CHOL, cholesterol; CREA, creatinine; FIB, fibrinogen; GLU, glucose; INR, international normalized ratio; PLT, platelet count; PTA, prothrombin activity; TBIL, total bilirubin; WBC, white blood cell count